Quarterly ResultAug 7, 2026, 01:23 PM
Encompass Health Q2 Net Income $153.9M, Revenue $1.6B
AI Summary
Encompass Health reported strong financial results for Q2 2026, with net income attributable to the company increasing to $153.9 million on revenues of $1.6 billion. For the first six months of 2026, net income rose to $348.4 million, and net operating revenues reached $3.18 billion. The company also completed a significant debt refinancing, issuing $500 million in new senior notes and entering into a new credit agreement, while increasing share repurchases and dividends.
Key Highlights
- Q2 2026 net income attributable to Encompass Health increased to $153.9M from $142.1M YoY.
- Q2 2026 net operating revenues rose to $1,597.4M from $1,457.7M YoY.
- Diluted EPS for Q2 2026 increased to $1.54 from $1.39 YoY.
- Issued $500M of 5.875% Senior Notes due 2034 in May 2026.
- Entered into a new credit agreement in March 2026, extending maturity to March 9, 2031.
- Net cash provided by operating activities increased to $595.7M for the six months ended June 30, 2026.
- Repurchased $145.8M of common stock and paid $39.2M in dividends for H1 2026.
- Recognized a $17.5M pre-tax gain from the sale of Gamma Knife membership interest.
Price Impact
More from EHC